-+ 0.00%
-+ 0.00%
-+ 0.00%

StenoCare warns potential Bedrocan medical cannabis supply disruption for Denmark from 2027

PUBT·10/02/2026 12:10:04
StenoCare warns potential Bedrocan medical cannabis supply disruption for Denmark from 2027
  • StenoCare flagged potential disruption to Danish supply of Bedrocan medical cannabis products from 2027 due to Dutch export changes.
  • Dutch Office of Medicinal Cannabis plans to end international exports by end-2026, creating a potential regulatory gap in 2027.
  • Bedrocan Nederland and Bedrocan International entered court-supervised suspension of payments amid contract expiry and delayed Dutch Opium Act changes.
  • StenoCare expects CannGros supply to continue through 2026, while seeking transitional options for 2027 and alternative sourcing.
  • Oil products supply across all markets is not affected.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. StenoCare A/S published the original content used to generate this news brief via Cision (Ref. ID: 20261002:BIT:8552:0) on October 02, 2026, and is solely responsible for the information contained therein.